Oncology Precision Medicine Market 규모 및 점유율 분석 - 성장 추세 및 예측 (2024 - 2031)

Oncology Precision Medicine Market is segmented By Type of Cancer (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer, Gastrointestinal Cancer, Head and Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer, Others), By Route of Administration (Oral, Intravenous, Others), By Type of Molecule (Small Molecules, Biologics), By Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Competitive overview of Oncology Precision Medicine Market

Global Oncology Precision Medicine Market에서 운영하는 주요 플레이어는 Amgen, BioNTech, Gilead Sciences, Merck & Co., Illumina, Foundation Medicine, Guardant Health, Caris Life Sciences, Exact Sciences, Myriad Genetics, Thermo Fisher Scientific, Invitae, Genomic Health, Syapse 및 Tempus를 포함합니다.

Oncology Precision Medicine Market Leaders

  • 카테고리
  • 인기 카테고리
  • 공장 투어
  • 브리스톨 마이어스 Squibb
  • 프로젝트
*Disclaimer: Major players are listed in no particular order.

Oncology Precision Medicine Market - Competitive Rivalry, 2023

Market Concentration Graph

Oncology Precision Medicine Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights